Quantcast

Latest ARYx Therapeutics Stories

2008-11-04 09:00:30

ARYx Therapeutics, a biopharmaceutical company, has completed enrollment in EmbraceAC, a Phase II/III double-blind clinical trial comparing its oral anticoagulation therapy, ATI-5923, against the leading anticoagulant agent, warfarin.

2008-08-29 12:01:17

ARYx Therapeutics, a biopharmaceutical company focused on developing a portfolio of potentially safer oral drugs, has appointed David Beier to its board of directors.


Word of the Day
taphephobia
  • A morbid dread of being buried alive. Also spelled 'taphiphobia'.
The word 'taphephobia' comes from Greek roots meaning 'burial' and 'fear'.
Related